Performing in vivo studies in an osteosarcoma model employing PLX3397, they also revealed a significant inhibition of primary tumor growth and lung metastasis, accompanied by M2-like TAM and Treg depletion, while also inducing the enhanced infiltration of CD8+ T cells within the TME [23]. The gene discussed is CD8A; the disease is neoplasm.